OliX Pharmaceuticals Announces Publication of Peer Reviewed Study in Molecular Pharmaceutics
March 12, 2020 10:00 ET
|
OliX Pharmaceuticals
SUWON, South Korea, March 12, 2020 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced the publication of a major study in the...